TITLE THE EFFICACY OF FIBRINOGEN CONCENTRATE COMPARED TO CRYOPRECIPITATE IN MAJOR OBSTETRIC HAEMORRHAGE – AN OBSERVATIONAL STUDY

Background Fibrinogen replacement is critical in major obstetric haemorrhage (MOH).Purified, pasteurized fibrinogen concentrate appears to have benefitover cryoprecipitate in ease of administration and safety but is unlicensed in pregnancy. In July 2009 the Irish Blood Transfusion Service replaced cryoprecipitate with fibrinogen.

[1]  A. Varon,et al.  Obstetric hemorrhage , 2015, Current opinion in anaesthesiology.

[2]  B. Sørensen,et al.  A critical evaluation of cryoprecipitate for replacement of fibrinogen , 2010, British journal of haematology.

[3]  J. Vincent,et al.  Management of bleeding following major trauma: an updated European guideline , 2010, Critical care.

[4]  P. Collins,et al.  The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. , 2010, International journal of obstetric anesthesia.

[5]  S. Daly,et al.  Near miss maternal morbidity. , 2008, Irish medical journal.

[6]  C. Wade,et al.  The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. , 2008, The Journal of trauma.

[7]  G. Penney,et al.  Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003–05 , 2007, BJOG : an international journal of obstetrics and gynaecology.

[8]  E. Samain,et al.  The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage , 2007, Journal of thrombosis and haemostasis : JTH.

[9]  P. Hamilton,et al.  Guidelines on the management of massive blood loss , 2006, British journal of haematology.

[10]  M S Jacobson,et al.  Normal reference laboratory values? , 1978, The New England journal of medicine.

[11]  G. Sher Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy. , 1977, American journal of obstetrics and gynecology.

[12]  J. Levy Massive transfusion coagulopathy. , 2006, Seminars in hematology.